Hemodynamic characterization of focal hepatic lesions: Role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo echo-planar sequence

Journal of Magnetic Resonance Imaging

Volumn 23, Issue 4, 2006, Pages 509-519

  Hori, Masatoshi ^a   Murakami, Takamichi ^a   Kim, Tonsok ^a   Iannaccone, Riccardo ^b   Abe, Hisashi ^a   Onishi, Hiromitsu ^a   Tomoda, Kaname ^a   Catalano, Carlo ^b   Passariello, Roberto ^b   Nakamura, Hironobu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Contrast media, effects; Functional studies; Liver neoplasms; MR imaging; Tumor staging

Indexed keywords

FERUCARBOTRAN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREATH HOLDING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; DEVICE; ECHO PLANAR IMAGING; FEMALE; HEMODYNAMICS; HUMAN; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER NODULE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; TUMOR CLASSIFICATION;

ADULT; AGED; AREA UNDER CURVE; CONTRAST MEDIA; ECHO-PLANAR IMAGING; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRAVENOUS; IRON; LIVER DISEASES; MALE; MIDDLE AGED; OXIDES; SENSITIVITY AND SPECIFICITY;

EID: 33645682847     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20542     Document Type: Article

References (22)

1. Bellin MF, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994;193:657-663.
2. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-466.
3. Hori M, Murakami T, Kim T, et al. Detection of hypervascular hepatocellular carcinoma: comparison of SPIO-enhanced MRI with dynamic helical CT. J Comput Assist Tomogr 2002;26:701-710.
4. Kang BK, Lim JH, Kim SH, et al. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 2003;226:79-85.
5. Ohtomo K, Itai Y, Yoshikawa K, et al. Hepatic tumors: dynamic MR imaging. Radiology 1987;163:27-31.
6. Van Beers B, Demeure R, Pringot J, et al. Dynamic spin-echo imaging with Gd-DTPA: value in the differentiation of hepatic tumors. AJR Am J Roentgenol 1990;154:515-519.
7. Bluemke DA, Weber TM, Rubin D, et al. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol. Radiology 2003;228:457-464.
8. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol 1990;155:943-950.
9. Ichikawa T, Arbab AS, Araki T, et al. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularlty in hepatocellular carcinoma. AJR Am J Roentgenol 1999;173:207-213.
10. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 2001;218:763-767.
11. Kim T, Murakami T, Hori M, et al. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol 2002;178:899-904.
12. Kumano S, Murakami T, Kim T, et al. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. AJR Am J Roentgenol 2003;181:1335-1339.
13. Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 2002;15:573-583.
14. Hahn PF, Stark DD, Weissleder R, Elizondo G, Saini S, Ferrucci JT, Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 1990;174:361-366.
15. Denys A, Arrive L, Servois V, et al. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 1994;193:665-669.
16. Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 1994;4:659-668.
17. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999;172:969-976.
18. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 2001;176:681-688.
19. Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985;154:25-29.
20. Trillaud H, Grenier N, Degreze P, Louail C, Chambon C, Franconi JM. First-pass evaluation of renal perfusion with TurboFLASH MR imaging and superparamagnetic iron oxide particles. J Magn Reson Imaging 1993;3:83-91.
21. Foo TK, Saranathan M, Prince MR, Chenevert TL. Automated detection of bolus arrival and initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Radiology 1997;203:275-280.
22. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Characterization of hepatic lesions by perfusion-weighted MR imaging with an echoplanar sequence. AJR Am J Roentgenol 1998;170:1029-1034.